drugset
drugset / Trial / NCT01156246

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

NCT01156246 ↗

Phase 1 Completed 18 enrolled AstraZeneca Bristol-Myers Squibb · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine whether treatment with a fixed dose combination dapagliflozin/metformin tablet is affected by food.

Timeline

Start
2010-06
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 5 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.